Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,842 | 405 | 71.9% |
| Consulting Fee | $4,933 | 3 | 27.6% |
| Education | $98.22 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,447 | 18 | $0 (2024) |
| LEO Pharma Inc. | $1,778 | 23 | $0 (2024) |
| UCB, Inc. | $1,510 | 8 | $0 (2024) |
| GENZYME CORPORATION | $1,294 | 33 | $0 (2024) |
| ABBVIE INC. | $1,167 | 56 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $935.85 | 30 | $0 (2024) |
| Journey Medical Corporation | $860.96 | 11 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $798.06 | 18 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $725.93 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $677.82 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,085 | 164 | E.R. Squibb & Sons, L.L.C. ($2,858) |
| 2023 | $6,148 | 145 | UCB, Inc. ($1,279) |
| 2022 | $2,633 | 58 | GENZYME CORPORATION ($407.27) |
| 2021 | $1,385 | 24 | Journey Medical Corporation ($304.73) |
| 2020 | $284.46 | 9 | Novartis Pharmaceuticals Corporation ($135.12) |
| 2019 | $337.02 | 10 | Regeneron Healthcare Solutions, Inc. ($139.25) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.71 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,762.50 | General |
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $81.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $125.10 | General |
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $69.83 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $65.71 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,791 | 2,949 | $402,705 | $145,303 |
| 2022 | 15 | 723 | 1,201 | $135,672 | $52,218 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 310 | 417 | $43,785 | $24,274 | 55.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 274 | 321 | $48,150 | $20,483 | 42.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 61 | 71 | $30,388 | $15,520 | 51.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 252 | 327 | $37,278 | $11,095 | 29.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 18 | 19 | $21,850 | $8,956 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 130 | 130 | $19,240 | $8,577 | 44.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 26 | 28 | $35,812 | $7,319 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 85 | $14,960 | $6,959 | 46.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 59 | 68 | $10,132 | $4,830 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $8,610 | $4,643 | 53.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 46 | 51 | $21,777 | $4,586 | 21.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 107 | 130 | $9,880 | $4,572 | 46.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 169 | 986 | $37,468 | $4,313 | 11.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 75 | 118 | $10,620 | $4,161 | 39.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 30 | 35 | $15,750 | $4,109 | 26.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $6,545 | $3,268 | 49.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 20 | 23 | $11,822 | $2,267 | 19.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 22 | 22 | $4,180 | $2,012 | 48.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $3,828 | $1,191 | 31.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $6,413 | $997.77 | 15.6% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $2,842 | $637.20 | 22.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 11 | 11 | $1,375 | $532.99 | 38.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 111 | 115 | $17,250 | $8,112 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 114 | $11,970 | $7,556 | 63.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 29 | 32 | $13,696 | $7,045 | 51.4% |
About Dr. Taylor Smith, M.D
Dr. Taylor Smith, M.D is a Dermatology healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1316444565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taylor Smith, M.D has received a total of $17,872 in payments from pharmaceutical and medical device companies, with $7,085 received in 2024. These payments were reported across 410 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,842).
As a Medicare-enrolled provider, Smith has provided services to 2,514 Medicare beneficiaries, totaling 4,150 services with total Medicare billing of $197,521. Data is available for 2 years (2022–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Rome, GA
- Active Since 04/12/2018
- Last Updated 07/29/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1316444565
Products in Payments
- ADBRY (Biological) $1,778
- DUPIXENT (Biological) $1,505
- VTAMA (Drug) $614.31
- Sotyktu (Drug) $603.54
- SKYRIZI (Biological) $590.78
- SILIQ (Drug) $552.43
- RINVOQ (Biological) $541.07
- COSENTYX (Drug) $443.98
- COSENTYX (Biological) $405.68
- OPZELURA (Drug) $399.65
- Zoryve (Drug) $381.46
- CLODERM (Drug) $345.66
- TREMFYA (Drug) $310.07
- EUCRISA (Drug) $299.68
- Otezla (Drug) $276.82
- TALTZ (Drug) $263.19
- Xeomin (Biological) $218.82
- Bimzelx (Biological) $169.70
- ILUMYA (Biological) $164.93
- Cimzia (Drug) $160.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.